Soumya Nadella, MD
Endocrinology, Diabetes & Metabolism · Chesterfield, MONPI 1316350028
Payments from drug & device makers
Across 411 payments — averaging $19.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$922
- Novo Nordisk$822
- Abbott$609
- Medtronic$558
- Sanofi-aventis U.S. LLC$445
- Tandem Diabetes Care, Inc.$427
- plus $4K from 34 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 53 | $922 |
| Novo Nordisk | 43 | $822 |
| Abbott | 40 | $609 |
| Medtronic(2 entities) | 14 | $558 |
| Sanofi-aventis U.S. LLC | 27 | $445 |
| Tandem Diabetes Care, Inc. | 13 | $427 |
| Amgen(2 entities) | 20 | $420 |
| Dexcom, Inc. | 18 | $409 |
| Novartis | 24 | $390 |
| AstraZeneca(2 entities) | 15 | $313 |
| Boehringer Ingelheim | 16 | $286 |
| AbbVie(2 entities) | 16 | $276 |
| Xeris Pharmaceuticals, Inc. | 12 | $272 |
| Mannkind Corporation | 11 | $196 |
| Recordati_rare_diseases_inc. | 8 | $174 |
| Sequel Med Tech, LLC | 9 | $158 |
| Insulet Corporation | 3 | $151 |
| IBSA Pharma Inc. | 8 | $132 |
| Esperion Therapeutics, Inc. | 7 | $122 |
| Corcept Therapeutics | 4 | $113 |
| Amarin Pharma, Inc. | 8 | $110 |
| Medicure Pharma Inc. | 1 | $105 |
| BETA Bionics, Inc. | 8 | $105 |
| Amneal Pharmaceuticals LLC | 5 | $75 |
| Bayer | 4 | $70 |
| Ascendis Pharma Endocrinology Inc | 3 | $62 |
| Nevro Corp. | 2 | $55 |
| Radius Health, Inc. | 3 | $50 |
| Antares Pharma, Inc. | 2 | $42 |
| Ultragenyx Pharmaceutical Inc. | 2 | $40 |
| Amryt Pharma Holdings Ltd | 2 | $37 |
| Almatica Pharma LLC | 2 | $35 |
| Neurocrine Biosciences, Inc. | 1 | $21 |
| Cequr Corporation | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Kyowa Kirin, Inc. | 1 | $19 |
| Merck | 1 | $17 |
| RGH Enterprises LLC | 1 | $16 |
| Ascensia Diabetes Care US Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $13 |
How this compares
$8,123 in reported general payments places this provider in the 70th percentile of 182 endocrinology, diabetes & metabolism providers in Missouri.
See all endocrinology, diabetes & metabolism providers in Missouri →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in Chesterfield
- Karen Chang-ChenChesterfield$640K
- Ralph OiknineChesterfield$414K
- Norman FishmanChesterfield$352K
- Ralph DudaSpringfield$3M
- Thomas NickolasSaint Louis$945K
- Anne GoldbergSaint Louis$830K
- Janet McGillSaint Louis$828K
- Christopher CaseJefferson City$692K
- Gregory LedgerSpringfield$690K
- Alan RaubaJefferson City$594K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.